In Byrnes v. Small, a Florida woman was allegedly injured in 2006 by a medical product that was implanted into her spine in a manner that was not approved by the nation’s Food and Drug Administration. In 2014, the allegedly injured woman filed a personal injury lawsuit against the company that designed, manufactured, and distributed the product that allegedly harmed her, her doctor, and his employer in a Florida state court. Soon afterward, the product manufacturer removed the woman’s case to the Middle District of Florida in Tampa based on diversity jurisdiction.
Federal diversity jurisdiction is appropriate under 28 U.S.C. Section 1332(a) when the parties to a lawsuit are citizens of different states and the amount in controversy exceeds $75,000. In general, the party seeking removal to federal court must demonstrate that federal jurisdiction was justified at the time the case was filed. According to the medical product manufacturer, the physician and his employer were fraudulently joined in the lawsuit in an effort to defeat federal jurisdiction. The manufacturer argued that such joinder was not permitted because the statute of limitations for filing a case against each of the other two defendants had passed. The manufacturer argued before the court that this meant the citizenship of the non-diverse defendants should be ignored. In response, the allegedly injured woman claimed the case should be remanded because the medical product manufacturer failed to meet its burden of demonstrating diversity.